Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: Evidence for cytotoxic mechanisms different from inhibition of protein synthesis

Cancer Research

Volumn 60, Issue 7, 2000, Pages 1983-1994

  Iordanov, Mihail S ^a   Ryabinina, Olga P ^a   Wong, John ^a   Dinh, Thanh Hoai ^a   Newton, Dianne L ^b   Rybak, Susanna M ^c   Magun, Bruce E ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; CYTOCHROME C OXIDASE; ENZYME PRECURSOR; FAS ANTIGEN; PROTEIN BAX; PROTEIN P53; RANPIRNASE; RIBONUCLEASE; TRANSFER RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ENZYME ACTIVATION; HELA CELL; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; PROTEIN TRANSPORT;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL DEATH; CELL SURVIVAL; CYCLOHEXIMIDE; CYTOCHROME C GROUP; EGG PROTEINS; EMETINE; HELA CELLS; HUMANS; LEUCINE; MITOCHONDRIA; PROTEIN BIOSYNTHESIS; PROTEIN SYNTHESIS INHIBITORS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RIBONUCLEASES; RNA, MESSENGER; RNA, TRANSFER; SUBSTRATE SPECIFICITY;

EID: 0034072727     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Green, D. R. Apoptotic pathways: the roads to ruin. Cell, 94: 695-698, 1998.
2. Ashkenazi, A., and Dixit, V. M. Death receptors: signaling and modulation. Science (Washington DC), 281: 1305-1308, 1998.
3. Green, D. R., and Reed, J. C. Mitochondria and apoptosis. Science (Washington DC), 281: 1309-1312, 1998.
4. Cohen, G. M. Caspases: the executioners of apoptosis. Biochem. J., 326; 1-16, 1997.
5. Cryns, V., and Yuan, J. Proteases to die for. Genes Dev., 12: 1551-1570, 1998.
6. Thornberry, N. A., and Lazebnik, Y. Caspases: enemies within. Science (Washington DC), 281: 1312-1316, 1998.
7. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E., and Dixit, V. M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell, 85: 817-827, 1996.
8. Srinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. S. Molecular ordering of the Fas-apoptotic pathway: the Fas/APO-1 protease Mch5 is a CrmA-inhihitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc. Natl. Acad. Sci. USA, 93: 14486-14491, 1996.
9. Stennicke, H. R., Jurgensmeier, J. M., Shin, H., Deveraux, Q., Wolf, B. B., Yang, X., Zhou, Q., Ellerby, H. M., Ellerhy, L. M., Bredesen, D., Green, D. R., Reed, J. C., Froclich, C. J., and Salvesen, G. S. Pro-caspase-3 is a major physiologic target of caspase-8. J. Biol. Chem., 273: 27084-27090, 1998.
10. Martin, D. A., Siegel, R. M., Zheng, L., and Lenardo, M. J. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHaα1) death signal. J. Biol. Chem., 273: 4345-4349, 1998.
11. Srinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T., and Alnemri, E. S. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell. 1: 949-957, 1998.
12. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., and Wang, X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91: 479-489, 1997.
13. Gonzales, D. H., and Neupert, W. Biogenesis of mitochondrial c-type cytochromes. J. Bioenerg. Biomembr., 22: 753-768, 1990.
14. Rosse, T., Olivier, R., Monney, L., Rager, M., Conus, S., Fellay, I., Jansen, B., and Borner, C. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature (Lond.), 391: 496-499, 1998.
15. Pastorino, J. G., Chen, S. T., Tafani, M., Snyder, J. W., and Farber, J. L. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J. Biol. Chem., 273: 7770-7775, 1998.
16. Jurgensmeier, J. M., Xie, Z., Deveraux, Q., Ellerby, L., Bredesen, D., and Reed, J. C. Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA. 95: 4997-5002, 1998.
17. 2+ ions. J. Cell Biol., 143: 217-224, 1998.
18. Narita, M., Shimizu, S., Ito, T., Chiltenden, T., Lutz, R. J., Matsuda, H., and Tsujimoto, Y. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc. Natl. Acad. Sci. USA, 95: 14681-14686, 1998.
19. Saikumar, P., Dong, Z., Patel, Y., Hall, K., Hopfer, U., Weinberg, J. M., and Venkatachalam, M. A. Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene. 17: 3401-3415, 1998.
20. Desagher, S., Osen-Sand, A., Nichols, A., Eskes, R., Montessuit, S., Lauper, S., Maundrell, K., Antonsson, B., and Martinou, J. C. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol., 144: 891-901, 1999.
21. Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Nagata, S. A. caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature (Lond.), 391: 43-50, 1998.
22. Shiokawa, D., and Tanuma, S. Molecular cloning and expression of a cDNA encoding an apoptotic endonuclease DNase-γ. Biochem. J., 332: 713-720, 1998.
23. Hakem, R., Hakem, A., Duncan, G. S., Henderson, J. T., Woo, M., Soengas, M. S., Elia, A., de la Pompa, J. L., Kagi, D., Khoo, W., Potter, J., Yoshida, R., Kaufman, S. A., Lowe, S. W., Penninger, J. M., and Mak, T. W. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell, 94: 339-352, 1998.
24. Kuida, K., Haydar, T. F., Kuan, C. Y., Gu, Y., Taya, C., Karasuyama, H., Su, M. S., Rakic, P., and Flavell, R. A. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell, 94: 325-337, 1998.
25. Yoshida, H., Kong, Y. Y., Yoshida, R., Elia, A. J., Hakem, A., Hakem, R., Penninger, J. M., and Mak, T. W. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell, 94: 739-750, 1998.
26. Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., and Green, D. R. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κ B and AP-1. Mol. Cell. 1: 543-551, 1998.
27. Friesen, C., Herr, I., Krammer, P. H., and Debatin, K. M. Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat. Med., 2: 574-577, 1996.
28. Herr, I., Wilhelm, D., Bohler, T., Angel, P., and Debatin, K. M. Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J., 16: 6200-6208, 1997.
29. Hansen, R., and Oren, M. p53: from inductive signal to cellular effect. Curr. Opin. Genet. Dev., 7: 46-51, 1997.
30. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
31. Darzynkiewicz, Z., Carter, S. P., Mikulski, S. M., Ardelt, W. J., and Shogen, K. Cytostatic and cytotoxic effects of Pannon (P-30 Protein), a novel anticancer agent. Cell Tissue Kinet., 21: 169-182, 1988.
32. Mikulski, S. M., Ardelt, W., Shogen, K., Bernstein, E. H., and Menduke, H. Striking increase of survival of mice bearing M109 Madison carcinoma treated with a novel protein from amphibian embryos. J. Natl. Cancer Inst., 82: 151-153, 1990.
33. Wu, Y., Mikulski, S. M., Ardelt, W., Rybak, S. M., and Youle, R. J. A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity. J. Biol. Chem., 268: 10686-10693, 1993.
34. Lin, J. J., Newton, D. L., Mikulski, S. M., Kung, H. F., Youle, R. J., and Rybak, S. M. Characterization of the mechanism of cellular and cell free protein synthesis inhibition by an anti-tumor ribonuclease. Biochem. Biophys. Res. Commun., 204: 156-162, 1994.
35. Rybak, S. M., Pearson, J. W., Fogler, W. E., Volker, K., Spence, S. E., Newton, D. L., Mikulski, S. M., Ardelt, W., Riggs, C. W., Kung, H. F., and Longo, D. L. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease. J. Natl. Cancer Inst., 88: 747-753, 1996.
36. Ardelt, W., Mikulski, S. M., and Shogen, K. Amino acid sequence of an anti-tumor protein from Rana pipiens oocytes and early embryos. Homology to pancreatic ribonucleases. J. Biol. Chem., 266: 245-251, 1991.
37. Schein, C. H. From housekeeper to microsurgeon: the diagnostic and therapeutic potential of ribonucleases. Nat. Biotechnol., 15: 529-536, 1997.
38. Mikulski, S. M., Newton, D. L., Wiltrout, R. H., and Rybak, S. M. Onconase and doxorubicin synergy in prolonging survival of MDA-MB-231 human breast cancer-bearing nude mice. Proc. Am. Assoc. Cancer Res. 40: 491, 1999.
39. Rybak, S. M., Saxena, S. K., Ackerman, E. J., and Youle, R. J. Cytotoxic potential of ribonuclease and ribonuclease hybrid proteins. J. Biol. Chem., 266: 21202-21207, 1991.
40. Leland, P. A., Schultz, L. W., Kim, B. M., and Raines, R. T. Ribonuclease A variants with potent cytotoxic activity. Proc. Natl. Acad. Sci. USA, 95: 10407-10412, 1998.
41. Iordanov, M. S., Pribnow, D., Magun, J. L., Dinh, T. H., Pearson, J. A., Chen, S. L., and Magun, B. E. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the α-sarcin/ricin loop in the 28S rRNA. Mol. Cell Biol., 17: 3373-3381, 1997.
42. Newton, D. L., Xue, Y., Boque, L., Wlodawer, A., Kung, H. F., and Rybak, S. M. Expression and characterization of a cytotoxic human-frog chimeric ribonuclease: potential for cancer therapy. Protein Eng., 10: 463-470, 1997.
43. Goillot, E., Raingeaud, J., Ranger, A., Tepper, R. I., Davis, R. J., Harlow, E., and Sanchez, I. Mitogen-activated protein kinase-mediated Fas apoptotic signaling pathway. Proc. Natl. Acad. Sci. USA, 94: 3302-3307, 1997
44. Pribnow, D., Muldoon, L. L., Fajardo, M., Theodor, L., Chen, L. Y., and Magun, B. E. Endothelin induces transcription of fos/jun family genes: a prominent role for calcium ion. Mol. Endocrinol., 6: 1003-1012, 1992.
45. Iordanov, M. S., Pribnow, D., Magun, J. L., Dinh, T. H., Pearson, J. A., and Magun, B. E. Ultraviolet radiation triggers the ribotoxic stress response in mammalian cells. J. Biol. Chem., 273: 15794-15803, 1998.
46. Bossy-Wetzel, E., Newmeyer, D. D., and Green, D. R. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J., 17: 37-49, 1998.
47. Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., and Earnshaw, W. C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature (Lond.), 371: 346-347, 1994.
48. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., and Dixit, V. M. Yama/CPP32 β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell. 81: 801-809, 1995.
49. Yaginuma, Y., and Westphal, H. Analysis of the p53 gene in human uterine carcinoma cell lines. Cancer Res., 51: 6506-6509, 1991.
50. Hoppe-Seyler, F., and Butz, K. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53. J. Virol., 67: 3111-3117, 1993.
51. Huibregtse, J. M., and Beaudenon, S. L. Mechanism of HPV E6 proteins in cellular transformation. Semin. Cancer Biol., 7: 317-326, 1996.
52. Oka, M., Hirazawa, K., Yamamoto, K., Iizuka, N., Hazama, S., Suzuki, T., and Kobayashi, N. Induction of Fas-mediated apoptosis on circulating lymphocytes by surgical stress. Ann. Surg., 223: 434-440, 1996.
53. Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J., Towne, E., Tracey, D., Wardwell, S., Wei, F-Y. Wong, W., Kamen R., and Seshadri, T. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL- 1β and resistant to endotoxic shock. Cell, 80: 401-411, 1995.
54. Smith, D. J., McGuire, M. J., Tocci, M. J., and Thiele, D. L. 1L-1β convertase (ICE) does not play a requisite role in apoptosis induced in T lymphoblasts by Fas-dependent or Fas-independent CTL effector mechanisms. J. Immunol., 158: 163-170, 1997.
55. Li, P., Allen, H., Banerjee, S., and Seshadri, T. Characterization of mice deficient in interleukin-1β converting enzyme. J. Cell. Biochem., 64: 27-32, 1997.
56. Kuwana, T., Smith, J. J., Muzio, M., Dixit, V., Newmeyer, D. D., and Kornbluth, S. Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J. Biol. Chem., 273: 16589-16594, 1998.
57. Li, H., Zhu, H., Xu, C. J., and Yuan, J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94: 491-501, 1998.
58. Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell, 94: 481-490, 1998.
59. Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Brenner, C., Larochette, N., Prevost, M. C., Alzari, P. M., and Kroemer, G. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J. Exp. Med., 189: 381-394, 1999.
60. Krajewski, S., Krajewska, M., Ellerby, L. M., Welsh, K., Xie, Z., Deveraux, Q. L., Salvesen, G. S., Bredesen, D. E., Rosenthal, R. E., Fiskum, G., and Reed, J. C. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl. Acad. Sci. USA, 96: 5752-5757, 1999.
61. Maggi, C. A. Therapeutic potential of capsaicin-like molecules: studies in animals and humans. Life Sci., 51: 1777-1781, 1992.
62. Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., and Julius, D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (Lond.), 389: 816-824, 1997.
63. Mikulski, S. M., Viera, A., Deptala, A., and Darzynkiewicz, Z. Enhanced in vitro cytotoxicity and cytostasis of the combination of onconase with a proteasome inhibitor. Int. J. Oncol., 13: 633-644, 1998.
64. Deptala, A., Halicka, H. D., Ardelt, B., Ardelt, W., Mikulski, S. M., Shogen, K., and Darzynkiewicz, Z. Potentiation of tumor necrosis factor induced apoptosis by onconase. Int. J. Oncol., 13: 11-16, 1998.
65. Kroemer, G., Dallaporta, B., and Resche-Rigon, M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol., 60: 619-642, 1998.
66. Keppler-Hafkemeyer, A., Brinkmann, U., and Pastan, I. Role of caspases in immunotoxin-induced apoptosis of cancer cells. Biochemistry, 37: 16934-16942, 1998.
67. Benhattar, J., Cerottini, J. P., Saraga, E., Metthez, G., and Givel, J. C. p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas. Int. J. Cancer, 69: 190-192, 1996.
68. Iwadate, Y., Fujimoto, S., Tagawa, M., Namba, H., Sueyoshi, K., Hirose, M., and Sakiyama, S. Association of p53 gene mutation with decreased chemosensitivity in human malignant gliomas. Int. J. Cancer, 69: 236-240, 1996.